AIM ImmunoTech Inc. (AIM)

AIM ImmunoTech Statistics

Total Valuation

AIM ImmunoTech has a market cap or net worth of $6.83 million. The enterprise value is $8.80 million.

Market Cap	6.83M
Enterprise Value	8.80M

Important Dates

The last earnings date was Thursday, August 14, 2025, after market close.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

AIM ImmunoTech has 2.71 million shares outstanding. The number of shares has increased by 34.14% in one year.

Current Share Class	2.71M
Shares Outstanding	2.71M
Shares Change (YoY)	+34.14%
Shares Change (QoQ)	+7.96%
Owned by Insiders (%)	4.39%
Owned by Institutions (%)	1.68%
Float	2.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	56.41
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	72.69
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.10

Current Ratio	0.10
Quick Ratio	0.08
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-27.36

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-104.62%
Return on Invested Capital (ROIC)	-362.96%
Return on Capital Employed (ROCE)	265.15%
Revenue Per Employee	$5,261
Profits Per Employee	-$702,870
Employee Count	23
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	0.40
52-Week Price Change	n/a
50-Day Moving Average	5.10
200-Day Moving Average	n/a
Relative Strength Index (RSI)	30.77
Average Volume (20 Days)	55,356

Short Selling Information

The latest short interest is 33,819, so 1.25% of the outstanding shares have been sold short.

Short Interest	33,819
Short Previous Month	8,176
Short % of Shares Out	1.25%
Short % of Float	1.31%
Short Ratio (days to cover)	0.09

Income Statement

In the last 12 months, AIM ImmunoTech had revenue of $121,000 and -$16.17 million in losses. Loss per share was -$24.12.

Revenue	121,000
Gross Profit	86,000
Operating Income	-16.61M
Pretax Income	n/a
Net Income	-16.17M
EBITDA	-16.37M
EBIT	-16.61M
Loss Per Share	-$24.12

Balance Sheet

The company has $835,000 in cash and $2.81 million in debt, giving a net cash position of -$1.97 million or -$0.73 per share.

Cash & Cash Equivalents	835,000
Total Debt	2.81M
Net Cash	-1.97M
Net Cash Per Share	-$0.73
Equity (Book Value)	-6.55M
Book Value Per Share	-8.57
Working Capital	-9.37M

Cash Flow

In the last 12 months, operating cash flow was -$10.96 million and capital expenditures -$18,000, giving a free cash flow of -$10.98 million.

Operating Cash Flow	-10.96M
Capital Expenditures	-18,000
Free Cash Flow	-10.98M
FCF Per Share	-$4.05

Margins

Gross Margin	71.07%
Operating Margin	-13,726.45%
Pretax Margin	-13,360.33%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AIM ImmunoTech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-34.14%
Shareholder Yield	-34.14%
Earnings Yield	-236.83%
FCF Yield	-160.78%

Analyst Forecast

The average price target for AIM ImmunoTech is $2.75, which is 6.59% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$2.75
Price Target Difference	6.59%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	270.24%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 12, 2025. It was a reverse split with a ratio of 1:100.

Last Split Date	Jun 12, 2025
Split Type	Reverse
Split Ratio	1:100

Scores

AIM ImmunoTech has an Altman Z-Score of -162.21 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-162.21
Piotroski F-Score	2